Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRA2A | P08913 | 17/20 | 0.53 |
| ▸ | ADRA2B | P18089 | 17/20 | 0.53 |
| ▸ | ADRA2C | P18825 | 17/20 | 0.53 |
| ▸ | NISCH | Q9Y2I1 | 3/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | HTR1A | P08908 | 2/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10981645 | 0.89 | ADRA2A (0.54) | ADRA2AADRA2BADRA2CNISCHTDP1 | |
| SCHEMBL10976651 | 0.86 | ADRA2A (0.52) | ADRA2AADRA2BADRA2CNISCH | |
| SCHEMBL3058505 | 0.77 | ADRA2A (0.53) | ADRA2AADRA2BADRA2CNISCHHTR1A | |
| SCHEMBL546178 | 0.77 | NISCH (0.50) | ADRA2AADRA2BADRA2CNISCHHTR1A | |
| SCHEMBL27797929 | 0.75 | NISCH (0.59) | ADRA2AADRA2BADRA2CNISCHHTR1A | |
| Hydrochloric Acid SCHEMBL3071166 | 0.74 | NISCH (0.57) | ADRA2AADRA2BADRA2CNISCHHTR1A | |
| SCHEMBL3065600 | 0.73 | ADRA2B (0.48) | ADRA2AADRA2BADRA2CNISCHHTR1A | |
| SCHEMBL11224297 | 0.71 | NISCH (0.54) | ADRA2AADRA2BADRA2CNISCHHTR1A | |
| Hydrochloric Acid SCHEMBL9655739 | 0.71 | ADRA2A (0.47) | ADRA2AADRA2BADRA2CNISCHMEN1 | |
| SCHEMBL3061010 | 0.70 | SMN1; SMN2 (0.45) | MEN1MAPK1KMT2AL3MBTL1TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100267795-A1 | NITROSUBSTITUTED ARYLOXYALKYLIMIDAZOLINES FOR USE AS PESTICIDES | SYNGENTA CROP PROTECTION, INC. (US) | 2010-10-21 | — | — | US | disclosed |
| US-20100267795-A1 | NITROSUBSTITUTED ARYLOXYALKYLIMIDAZOLINES FOR USE AS PESTICIDES | SYNGENTA CROP PROTECTION, INC. (US) | 2010-10-21 | — | — | US | disclosed |
| WO-2009060173-A1 | NITROSUBSTITUTED ARYLOXYALKYLIMIDAZOLINES FOR USE AS PESTICIDES | SYNGENTA PARTICIPATIONS AG (CH) | 2009-05-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100267795-A1 | NITROSUBSTITUTED ARYLOXYALKYLIMIDAZOLINES FOR USE AS PESTICIDES | NISCH, DDT, CBR3 | ADRA2A 1472/4885ADRA2B 884/4885ADRA2C 437/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.